TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Ajanta Pharmaceuticals Ltd.

AJANTPHARM on NSE · 19 Nov 2026

NIFTY 500

3,270.30 ▼ -0.11 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

Guidance tracker

What AJANTPHARM guided, and what came next

FiledWhat the filing saysNext results: profit YoYRevenueMove on the day
30 Oct 2026Board approved unaudited consolidated and standalone financial results for Q2 and half year ended 30 September 2026 (board meeting held 30 October 2026, 11:30 a.m. to 12:50 p.m.). Q2 FY2027 consolidated revenue from operations Rs 1,794 cr vs Rs 1,354 cr (up 33%); adjusted EBITDA (excluding forex loss) Rs 543 cr vs... NSE copy No results filed since

Filings tagged as guidance, newest first (1 in all), with the company's next results after each: profit and revenue against the same quarter a year before, and the share's move on the results day. Whether the guidance was met is for the reader to judge from both; the site does not score it. The summaries are written by an AI model from the filing and can be wrong - the filing is the source.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in